Lawrence A. Kenyon
2018
In 2018, Lawrence A. Kenyon earned a total compensation of $716.1K as Director, Chief Executive Officer, President, Chief Financial Officer, Treasurer and Corporate Secretary at Outlook Therapeutics, a 20% increase compared to previous year.
Compensation breakdown
| Option Awards | $326,192 |
|---|---|
| Salary | $371,635 |
| Other | $18,305 |
| Total | $716,132 |
Kenyon received $371.6K in salary, accounting for 52% of the total pay in 2018.
Kenyon also received $326.2K in option awards and $18.3K in other compensation.
Rankings
In 2018, Lawrence A. Kenyon's compensation ranked 10,623rd out of 14,244 executives tracked by ExecPay. In other words, Kenyon earned more than 25.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,623 out of 14,244 | 25th |
Division Manufacturing | 4,275 out of 5,758 | 26th |
Major group Chemicals And Allied Products | 1,607 out of 2,119 | 24th |
Industry group Drugs | 1,356 out of 1,808 | 25th |
Industry Biological Products, Except Diagnostic Substances | 263 out of 339 | 22nd |
Source: SEC filing on August 1, 2019.
Kenyon's colleagues
We found three more compensation records of executives who worked with Lawrence A. Kenyon at Outlook Therapeutics in 2018.